Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Pantoprazole sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pantoprazole sodium and what is the scope of pantoprazole sodium freedom to operate?

Pantoprazole sodium
is the generic ingredient in three branded drugs marketed by Jubilant Generics, Apotex Inc, Amneal Pharms, Dr Reddys Labs Ltd, Wyeth Pharms Inc, Macleods Pharms Ltd, Perrigo R And D, Wockhardt, Aurobindo Pharma Ltd, Orchid Hlthcare, Teva, Sun Pharm Inds Ltd, Mylan Pharms Inc, Torrent Pharms, Kremers Urban Pharms, Hetero Labs Ltd V, Sandoz Inc, Akorn Inc, and Actavis Totowa, and is included in twenty-three NDAs. There are nine patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Pantoprazole sodium has ninety-eight patent family members in forty-seven countries.

There are forty-six drug master file entries for pantoprazole sodium. Fifty-nine suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: pantoprazole sodium

Tradenames:3
Patents:9
Applicants:19
NDAs:23
Drug Master File Entries: see list46
Suppliers / Packagers: see list59
Bulk Api Vendors: see list105
Clinical Trials: see list979
Patent Applications: see list6,034
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pantoprazole sodium at DailyMed

Pharmacology for Ingredient: pantoprazole sodium

Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors

Tentative approvals for PANTOPRAZOLE SODIUM

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe40MGINJECTABLE; INJECTION
► Subscribe► SubscribeEQ 40MG BASE/VIALINJECTABLE; IV (INFUSION)
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL202038-002Sep 28, 2012ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL077619-002Jan 19, 2011ABRXNoNo► Subscribe► Subscribe
Apotex Inc
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL090807-002May 2, 2012ABRXNoNo► Subscribe► Subscribe
Actavis Totowa
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL090797-001Feb 7, 2011ABRXNoNo► Subscribe► Subscribe
Perrigo R And D
PANTOPRAZOLE SODIUM
pantoprazole sodium
TABLET, DELAYED RELEASE;ORAL203024-001May 7, 2014ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot